- 专利标题: Methods and kits for classifying diffuse large B-cell lymphomas (DLBCLs) into GCB-DLBCLs or into ABC-DLBCLs
-
申请号: US15124580申请日: 2015-03-10
-
公开(公告)号: US10519508B2公开(公告)日: 2019-12-31
- 发明人: Fabrice Jardin , Philippe Ruminy , Sylvain Mareschal , Vinciane Marchand , Cristina Bagacean
- 申请人: INSERM (Institute National de la Sante et de la Recherche Medicale) , Universite de Rouen , Centre Henri Becquerel
- 申请人地址: FR Paris FR Mont-Saint-Aignan FR Rouen
- 专利权人: INSERM (Institut National de la Sante et de la Recherche Medicale),Universite de Rouen,Centre Henri Becquerrel
- 当前专利权人: INSERM (Institut National de la Sante et de la Recherche Medicale),Universite de Rouen,Centre Henri Becquerrel
- 当前专利权人地址: FR Paris FR Mont-Saint-Aignan FR Rouen
- 代理机构: W & C IP
- 优先权: EP14305350 20140311
- 国际申请: PCT/EP2015/054952 WO 20150310
- 国际公布: WO2015/135935 WO 20150917
- 主分类号: C12Q1/6886
- IPC分类号: C12Q1/6886
摘要:
The present invention relates to a method for classifying a diffuse large B-cell lymphoma (DLBCL) of a subject into a GCB-DLBCL or into a ABC-DLBCL comprising the step of determining the expression level of 10 genes in a tumor tissue sample obtained from the subject by performing a Reverse Transcriptase Multiplex Ligation dependent Probe Amplification (RT-MLPA) assay wherein the 10 genes are NEK6, IRF4, IGHM, LMO2, FOXP1, TNFRSF9, BCL6, TNFRSF13B, CCND2 and MYBL1.
公开/授权文献
信息查询
IPC分类: